Iftekhar Kalsekar

2.5k total citations
99 papers, 1.7k citations indexed

About

Iftekhar Kalsekar is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Iftekhar Kalsekar has authored 99 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 18 papers in Cardiology and Cardiovascular Medicine and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Iftekhar Kalsekar's work include Diabetes Treatment and Management (16 papers), Lung Cancer Diagnosis and Treatment (15 papers) and Atrial Fibrillation Management and Outcomes (13 papers). Iftekhar Kalsekar is often cited by papers focused on Diabetes Treatment and Management (16 papers), Lung Cancer Diagnosis and Treatment (15 papers) and Atrial Fibrillation Management and Outcomes (13 papers). Iftekhar Kalsekar collaborates with scholars based in United States, United Kingdom and Germany. Iftekhar Kalsekar's co-authors include Kimberly Horn, Geri Dino, Stephen S. Johnston, Ancilla W. Fernandes, Tony Hebden, Hiep Nguyen, Andrew Yoo, Eric M. Ammann, John J. Sheehan and Kelly Bell and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Stroke.

In The Last Decade

Iftekhar Kalsekar

92 papers receiving 1.6k citations

Peers

Iftekhar Kalsekar
Risa P. Hayes United States
Antoni Sicras‐Mainar Spain
Blair Anton United States
Patricia Montague Canada
Fadia T. Shaya United States
Christine T. Cigolle United States
Amy S. Jeffreys United States
David Yanez United States
Rimke C. Vos Netherlands
Valeria Saglimbene Australia
Risa P. Hayes United States
Iftekhar Kalsekar
Citations per year, relative to Iftekhar Kalsekar Iftekhar Kalsekar (= 1×) peers Risa P. Hayes

Countries citing papers authored by Iftekhar Kalsekar

Since Specialization
Citations

This map shows the geographic impact of Iftekhar Kalsekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iftekhar Kalsekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iftekhar Kalsekar more than expected).

Fields of papers citing papers by Iftekhar Kalsekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iftekhar Kalsekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iftekhar Kalsekar. The network helps show where Iftekhar Kalsekar may publish in the future.

Co-authorship network of co-authors of Iftekhar Kalsekar

This figure shows the co-authorship network connecting the top 25 collaborators of Iftekhar Kalsekar. A scholar is included among the top collaborators of Iftekhar Kalsekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iftekhar Kalsekar. Iftekhar Kalsekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zongzhi, David Corrigan, Iftekhar Kalsekar, et al.. (2025). Decoding Recurrence in Early-Stage and Locoregionally Advanced Non–Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing. JCO Clinical Cancer Informatics. 9(9). e2400227–e2400227.
2.
Murgu, Septimiu, Balaji Laxmanan, Charlene A. Wong, et al.. (2025). Procedure Patterns and Survival in Advanced Non-Small Cell Lung Cancer With Malignant Airway Obstruction. CHEST Journal. 169(2). 538–549.
3.
4.
Laeseke, Paul F., Calvin S.H. Ng, Nicole Ferko, et al.. (2023). Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: A systematic literature review and meta-analysis. Lung Cancer. 182. 107259–107259. 18 indexed citations
5.
Liu, Zongzhi, Urmila Chandran, Iftekhar Kalsekar, et al.. (2023). Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning–Based Natural Language Processing. SHILAP Revista de lepidopterología. 2. e44537–e44537. 6 indexed citations
6.
Janssen, Ellen M., Ian Smith, Xiaoying Liu, et al.. (2023). Patient Preferences for Lung Cancer Interception Therapy. JAMA Network Open. 6(11). e2342681–e2342681. 3 indexed citations
7.
Chandran, Urmila, Jenna Reps, Robert Yang, et al.. (2022). Machine Learning and Real-World Data to Predict Lung Cancer Risk in Routine Care. Cancer Epidemiology Biomarkers & Prevention. 32(3). 337–343. 22 indexed citations
8.
Khanna, Rahul, Robert W. Yeh, Laura Goldstein, et al.. (2021). Limited duration of antiarrhythmic drug use for newly diagnosed atrial fibrillation in a nationwide population under age 65. Journal of Cardiovascular Electrophysiology. 32(6). 1529–1537. 3 indexed citations
9.
Khanna, Rahul, Robert W. Yeh, Laura Goldstein, et al.. (2020). Trends and predictors of early ablation for Atrial Fibrillation in a Nationwide population under age 65: a retrospective observational study. BMC Cardiovascular Disorders. 20(1). 161–161. 6 indexed citations
10.
11.
Field, Michael E., Michael R. Gold, Matthew R. Reynolds, et al.. (2019). Real‐world outcomes of ventricular tachycardia catheter ablation with versus without intracardiac echocardiography. Journal of Cardiovascular Electrophysiology. 31(2). 417–422. 21 indexed citations
12.
13.
MacEwan, Joanna P., John J. Sheehan, J. Vanderpuye-Orgle, et al.. (2017). The relationship between adherence and total spending among Medicare beneficiaries with type 2 diabetes.. PubMed. 23(4). 248–252. 2 indexed citations
14.
Yoo, Andrew, et al.. (2016). Economic Burden of Hysterectomies in the United States: Incremental Effects in Cancer Patients. Value in Health. 19(3). A148–A148. 2 indexed citations
15.
Saunders, W. Brian, Hiep Nguyen, & Iftekhar Kalsekar. (2016). Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study. Diabetes Metabolic Syndrome and Obesity. Volume 9. 217–223. 17 indexed citations
16.
Chang, Trina, Yonghua Jing, Albert Yeung, et al.. (2012). Effect of communicating depression severity on physician prescribing patterns: findings from the Clinical Outcomes in MEasurement-based Treatment (COMET) trial. General Hospital Psychiatry. 34(2). 105–112. 24 indexed citations
17.
Kalsekar, Iftekhar, et al.. (2011). Impact of ACE inhibitors on mortality and morbidity in patients with AMI: Does tissue selectivity matter?. Value in Health. 14(1). 184–191. 2 indexed citations
18.
Kalsekar, Iftekhar, et al.. (2010). Economic and Utilization Burden of Hospital-Acquired Pneumonia (HAP): A Systematic Review and Meta-analysis. CHEST Journal. 138(4). 739A–739A. 3 indexed citations
19.
Dino, Geri, et al.. (2008). Cost-Effectiveness Analysis of the Not On Tobacco Program for Adolescent Smoking Cessation. Prevention Science. 9(1). 38–46. 36 indexed citations
20.
Dino, Geri, et al.. (2003). Recruitment Barriers and Successes of the American Lung Association's Not‐On‐Tobacco Program. Journal of School Health. 73(2). 58–63. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Risa P. Hayes Breakdown of academic impact, for papers by Antoni Sicras‐Mainar Breakdown of academic impact, for papers by Blair Anton Breakdown of academic impact, for papers by Patricia Montague Breakdown of academic impact, for papers by Fadia T. Shaya Breakdown of academic impact, for papers by Christine T. Cigolle Breakdown of academic impact, for papers by Amy S. Jeffreys Breakdown of academic impact, for papers by David Yanez Breakdown of academic impact, for papers by Rimke C. Vos Breakdown of academic impact, for papers by Valeria Saglimbene
Rankless by CCL
2026